Beneficial effect of 3,4,5,6-tetrahydroxyxanthone on dyslipidemia in apolipoprotein E-deficient mice

Canadian Journal of Physiology and Pharmacology

Volumn 86, Issue 12, 2008, Pages 815-826

  Xiao, Hong Bo ^a   Sun, Zhi Liang ^a   Lu, Xiang Yang ^a   Li, Da Zhi ^b   Xu, Jian Ping ^a   Hu, Ya Ping ^a  

^a HUNAN AGRICULTURAL UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

3,4,5,6 tetrahydroxyxanthone; Angiopoietin like protein 3; Apolipoprotein E deficient mice; High density lipoprotein cholesterol; Lipoprotein lipase; Total cholesterol; Triglyceride

Indexed keywords

3,4,5,6 TETRAHYDROXYXANTHONE; ANGIOPOIETIN; ANGIOPOIETIN LIKE PROTEIN 3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; XANTHONE DERIVATIVE;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DYSLIPIDEMIA; GENE EXPRESSION; HYPERLIPOPROTEINEMIA TYPE 3; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANGIOPOIETINS; ANIMALS; APOLIPOPROTEINS E; CELLS, CULTURED; CHOLESTEROL; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; HYDROCARBONS, FLUORINATED; LIPOPROTEIN LIPASE; LIVER; MALE; MICE; MICE, KNOCKOUT; RANDOM ALLOCATION; RNA, MESSENGER; SULFONAMIDES; TRIGLYCERIDES; XANTHONES;

EID: 57349090167     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y08-091     Document Type: Article

References (51)

1. Ando, Y., Shimizugawa, T., Takeshita, S., Ono, M., Shimamura, M., Koishi, R., et al. 2003. A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice. J. Lipid Res. 44: 1216-1223. doi:10.1194/jlr.M300031-JLR200. PMID:12671033.
2. Baba, S., Natsume, M., Yasuda, A., Nakamura, Y., Tamura, T., Osakabe, N., et al. 2007. Plasma LDL and HDL cholesterol and oxidized LDL concentrations are altered in normo- and hypercholesterolemic humans after intake of different levels of cocoa powder. J. Nutr. 137: 1436-1441. PMID:17513403.
3. Benlian, P., De Gennes, J.L., Foubert, L., Zhang, H., Gagné, S.E., and Hayden, M. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854. doi:10.1056/NEJM199609193351203. PMID:8778602.
4. Bucher, K.D., Friedlander, Y., Kaplan, E.B., Namboodiri, K.K., Kark, J.D., Eisenberg, S., et al. 1988. Biological and cultural sources of familial resemblance in plasma lipids: a comparison between North America and Israel - the Lipid Research Clinics Program. Genet. Epidemiol. 5: 17-33. doi:10.1002/gepi.1370050103. PMID:3360301.
5. Camenisch, G., Pisabarro, M.T., Sherman, D., Kowalski, J., Nagel, M., Hass, P., et al. 2002. ANGPTL3 stimulates endothelial cell adhesion and migration via integrin alpha vbeta 3 and induces blood vessel formation in vivo. J. Biol. Chem. 277: 17281-17290. doi:10.1074/jbc.M109768200. PMID:11877390.
6. Chang, C.H., Lin, C.C., Hattori, M., and Namba, T. 1994. Effects on anti-lipid peroxidation of Cudrania cochinchinensis var. gerontogea. J. Ethnopharmacol. 44: 79-85. doi:10.1016/0378- 8741(94)90072-8. PMID:7853868.
7. Conklin, D., Gilbertson, D., Taft, D.W., Maurer, M.F., Whitmore, T.E., Smith, D.L., et al. 1999. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics, 62: 477-482. doi:10.1006/geno.1999.6041. PMID:10644446.
8. Criqui, M.H., Heiss, G., Cohn, R., Cowan, L.D., Suchindran, C.M., Bangdiwala, S., et al. 1993. Plasma triglyceride level and mortality from coronary heart disease. N. Engl. J. Med. 328: 1220-1225. doi:10.1056/NEJM199304293281702. PMID:8464432.
9. Dai, Z., Liao, D.F., Jiang, D.J., Deng, H.W., and Li, Y.J. 2004. 3,4,5,6-tetrahydroxyxanthone prevents vascular endothelial cell apoptosis induced by high glucose. Naunyn Schmiedebergs Arch. Pharmacol. 370: 314-319. doi:10.1007/s00210-004-0973-y. PMID:15338110.
10. Fujimoto, K., Koishi, R., Shimizugawa, T., and Ando, Y. 2006. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity. Exp. Anim. 55: 27-34. doi:10.1538/expanim.55.27. PMID:16508209.
11. Geurian, K., Pinson, J.B., and Weart, C.W. 1992. The triglyceride connection in atherosclerosis. Ann. Pharmacother. 26: 1109-1117. PMID:1421678.
12. Gonda, R., Takeda, T., and Akiyama, T. 2000. Studies on the constituents of Anaxagorea luzonensis A. GRAY. Chem. Pharm. Bull. (Tokyo), 48: 1219-1222. PMID:10959592.
13. Gotto, A.M., Jr. 1998. Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 82: 22Q-25Q. PMID:9671003.
14. Hasty, A.H., Shimano, H., Osuga, J., Namatame, I., Takahashi, A., Yahagi, N., et al. 2001. Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor. J. Biol. Chem. 276: 37402-37408. doi:10.1074/jbc.M010176200.
15. Hatsuda, S., Shoji, T., Shinohara, K., Kimoto, E., Mori, K., Fukumoto, S., et al. 2007. Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects. J. Vasc. Res. 44: 61-66. doi:10.1159/000098153. PMID: 17191020.
16. Huang, Y., Rall, S.C., Jr., and Mahley, R.W. 1997. Genetic factors precipitating type III hyperlipoproteinemia in hypolipidemic transgenic mice expressing human apolipoprotein E2. Arterioscler. Thromb. Vasc. Biol. 17: 2817-2824. PMID:9409260.
17. Inaba, T., Matsuda, M., Shimamura, M., Takei, N., Terasaka, N., Ando, Y., et al. 2003. Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor. J. Biol. Chem. 278: 21344-21351. doi:10.1074/jbc.M213202200. PMID:12672813.
18. Inukai, K., Nakashima, Y., Watanabe, M., Kurihara, S., Awata, T., Katagiri, H., et al. 2004. ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states. Biochem. Biophys. Res. Commun. 317: 1075-1079. doi:10.1016/j.bbrc.2004.03.151. PMID:15094378.
19. Ishiguro, K., Nagata, S., Oku, H., and Yamaki, M. 2002. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. Planta Med. 68: 258-261. doi:10.1055/s-2002-23125. PMID:11914965.
20. Jiang, D.J., Hu, G.Y., Jiang, J.L., Xiang, H.L., Deng, H.W., and Li, Y.J. 2003a. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors. Bioorg. Med. Chem. 11: 5171-5177. doi:10.1016/j.bmc.2003.08.015. PMID:14604680.
21. Jiang, D.J., Jiang, J.L., Tan, G.S., Du, Y.H., Xu, K.P., and Li, Y.J. 2003b. Protective effects of daviditin A against endothelial damage induced by lysophosphatidylcholine. Naunyn Schmiedebergs Arch. Pharmacol. 367: 600-606. doi:10.1007/s00210-003-0756-x. PMID:12750878.
22. Jiang, D.J., Jiang, J.L., Zhu, H.Q., Tan, G.S., Liu, S.Q., Xu, K.P., et al. 2004. Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. J. Ethnopharmacol. 93: 295-306. doi:10.1016/j.jep.2004.03.055. PMID:15234768.
23. Kaplan, R., Zhang, T., Hernandez, M., Gan, F.X., Wright, S.D., Waters, M.G., et al. 2003. Regulation of the angiopoietin-like protein 3 gene by LXR. J. Lipid Res. 44: 136-143. doi:10.1194/jlr.M200367-JLR200. PMID:12518032.
24. Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N.P., Rieder, M.J., et al. 2008. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40: 189-197. doi:10.1038/ng.75. PMID:18193044.
25. Kersten, S. 2005. Regulation of lipid metabolism via angiopoietin-like proteins. Biochem. Soc. Trans. 33: 1059-1062. doi:10.1042/BST20051059. PMID:16246045.
26. Koishi, R., Ando, Y., Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., et al. 2002. Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30: 151-157. doi:10.1038/ng814. PMID:11788823.
27. Korstanje, R., Eriksson, P., Samnegard, A., Olsson, P.G., Forsman-Semb, K., Sen, S., et al. 2004. Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans. Atherosclerosis, 177: 443-450. doi:10.1161/ATVBAHA.107.148106. PMID:15530921.
28. Köster, A., Chao, Y.B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P.A., Hale, J.E., et al. 2005. Transgenic angiopoietin-like (angptl) 4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism. Endocrinology, 146: 4943-4950. doi:10.1210/en.2005-0476. PMID:16081640.
29. Levin, N., Bischoff, E.D., Daige, C.L., Thomas, D., Vu, C.T., Heyman, R.A., et al. 2005. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler. Thromb. Vasc. Biol. 25: 135-142. doi:10.1161/01.ATV.0000178996.91277.fb. PMID:15539622.
30. Mahabusarakam, W., Proudfoot, J., Taylor, W., and Croft, K. 2000. Inhibition of lipoprotein oxidation by prenylatted xanthones derived from mangostin. Free Radic. Res. 33: 643-659. doi:10.1080/10715760000301161. PMID:11200095.
31. Marcil, V., Delvin, E., Sané, A.T., Tremblay, A., and Levy, E. 2006. Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardiovasc. Res. 72: 473-482. doi:10.1016/j.cardiores.2006.08.024. PMID:17070507.
32. Miida, T., Seino, U., Miyazaki, O., Hanyu, O., Hirayama, S., Saito, T., et al. 2008. Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling. Atherosclerosis, 200(2): 329-335. doi:10.1016/j.atherosclerosis.2007.12. 031. PMID:18279878.
33. Minami, H., Takahashi, E., Fukuyama, Y., Kodama, M., Yoshizawa, T., and Nakagawa, K. 1995. Novel xanthones with superoxide scavenging activity from Garciniasubelliptica. Chem. Pharm. Bull. (Tokyo), 43: 347-349. PMID:7728938.
34. Moon, H.S., Chung, C.S., Lee, H.G., Kim, T.G., Choi, Y.J., and Cho, C.S. 2007. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity (Silver Spring), 15: 2571-2582. doi:10.1038/oby.2007.309. PMID:18070748.
35. Ono, M., Shimizugawa, T., Shimamura, M., Yoshida, K., Noji-Sakikawa, C., Ando, Y., et al. 2003. Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3). J. Biol. Chem. 278: 41804-41809. doi:10.1074/jbc.M302861200. PMID:12909640.
36. Pal, S., Ho, N., Santos, C., Dubois, P., Mamo, J., Croft, K., et al. 2003. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. J. Nutr. 133: 700-706. PMID:12612140.
37. Rice, T., Vogler, G.P., Perry, T.S., Laskarzewski, P.M., and Rao, D.C. 1991. Familial aggregation of lipids and lipoproteins in families through random and nonrandom probands in the Iowa Lipid Research Clinics family study. Hum. Hered. 41: 107-121. doi:10.1159/000153987. PMID:1855782.
38. Shimamura, M., Matsuda, M., Ando, Y., Koishi, R., Yasumo, H., Furukawa, H., et al. 2004. Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor. Biochem. Biophys. Res. Commun. 322: 1080-1085. doi:10.1016/j.bbrc.2004.08.024. PMID:15336575.
39. Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., et al. 2007. Angiopoietin-like protein 3 regulates plasma HDL cholesterol through suppression of endothelial lipase. Arterioscler. Thromb. Vasc. Biol. 27: 366-372. doi:10.1161/01.ATV.0000252827.51626.89. PMID:17110602.
40. Shimizugawa, T., Ono, M., Shimamura, M., Yoshida, K., Ando, Y., Koishi, R., et al. 2002. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase. J. Biol. Chem. 277: 33742-33748. doi:10.1074/jbc.M203215200. PMID:12097324.
41. Stejskal, D., Karpísek, M., Humenanská, V., Solichová, P., and Stejskal, P. 2007. Angiopoietin-like protein 3: development, analytical characterization, and clinical testing of a new ELISA. Gen. Physiol. Biophys. 26: 230-233. PMID:18063851.
42. Subrahmanyan, L., and Kisilevsky, R. 1988. Effects of culture substrates and normal hepatic sinusoidal cells on in vitro hepatocyte synthesis of Apo-SAA. Scand. J. Immunol. 27: 251-260. doi:10.1111/j.1365-3083.1988.tb02345.x. PMID:3353686.
43. Sun, W.L., Chen, L.L., Yan, J., and Yu, Z.S. 2005. Effects of IGFII on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell. J. Zhejiang Univ. Sci. B, 6: 699-704. doi:10.1631/jzus.2005.B0699. PMID:15973776.
44. Thomas, S.S., Plenkiewicz, J., Ison, E.R., Bols, M., Zou, W., Szarek, W.A., et al. 1995. Influence of monosaccharide derivatives on liver cell glycosaminoglycan synthesis: 3-deoxy-D-xylo-hexose (3-deoxy-D- galactose) and methyl (methyl 4-chloro-4-deoxy-beta-D-galactopyranosid) uronate. Biochim. Biophys. Acta, 1272: 37-48. PMID:7662718.
45. Tsutsumi, K. 2003. Lipoprotein lipase and atherosclerosis. Curr. Vasc. Pharmacol. 1: 11-17. doi:10.2174/1570161033386673.
46. Tsutsumi, K., Inoue, Y., Shima, A., Iwasaki, K., Kawamura, M., and Murase, T. 1993. The novel compound NO-1886 increases lipoprotein lipase activity with resulting elevation of high density lipoprotein cholesterol, and long-term administration inhibits atherogenesis in the coronary arteries of rats with experimental atheroclerosis. J. Clin. Invest. 92: 411-417. doi:10.1172/JCI116582. PMID:8326009.
47. Willer, C.J., Sanna, S., Jackson, A.U., Scuteri, A., Bonnycastle, L.L., Clarke, R., et al. 2008. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40: 161-169. doi:10.1038/ng.76. PMID:18193043.
48. Yagyu, H., Ishibashi, S., Chen, Z., Osuga, J., Okazaki, M., Perrey, S., et al. 1999. Overexpressed lipoprotein lipase protects against atheroclerosis in apolipoprotein E knockout mice. J. Lipid Res. 40: 1677-1685. PMID:10484615.
49. Yagyu, H., Lutz, E.P., Kako, Y., Marks, S., Hu, Y., Choi, S.Y., et al. 2002. Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity: possible causes of hypertriglyceridemia and reduced body mass with VLDL receptor deficiency. J. Biol. Chem. 277: 10037-10043. doi:10.1074/jbc.M109966200. PMID:11790777.
50. Zhang, A.H., Gao, S., Fan, J.L., Huang, W., Zhao, T.Q., and Liu, G. 2004. Increased plasma HDL cholesterol levels and biliary cholesterol excretion in hamster by LCAT overexpression. FEBS Lett. 570: 25-29. doi:10.1016/j.febslet.2004.06.017. PMID:15251433.
51. Zhao, W.H., Zhang, J., Zhai, Y., You, Y., Man, Q.Q., Wang, C.R., et al. 2007. Blood lipid profile and prevalence of dyslipidemia in Chinese adults. Biomed. Environ. Sci. 20: 329-335. doi:10.1159/000107519. PMID:17948769.